EMA reconsiders and gives its positive opinion for the approval of ixazomibAccess, Myeloma17 September 2016
MPE encourages EMA to review its negative recommendation for ixazomibAccess, MPE, Myeloma16 August 2016
MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, Myeloma24 June 2016
